SYNLOGIC, INC. Restructuring Charges
SYNLOGIC, INC. (SYBX) reported Restructuring Charges of $174.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2026-08-11
- SYNLOGIC, INC. restructuring charges for the quarter ending 2026-06-30 was $174.00K.
- SYNLOGIC, INC. restructuring charges for the quarter ending 2026-03-31 was $206.00K, a 415.00% increase year-over-year.
- SYNLOGIC, INC. restructuring charges for the quarter ending 2025-12-31 was $280.00K, a 26.89% decline year-over-year.
- SYNLOGIC, INC. restructuring charges for the quarter ending 2025-09-30 was $165.00K, a 44.26% decline year-over-year.
- SYNLOGIC, INC. restructuring charges for fiscal 2025 was $476.00K, a 98.11% decline from fiscal 2024.
- SYNLOGIC, INC. restructuring charges for fiscal 2024 was $25.17M.
- SYNLOGIC, INC. restructuring charges for fiscal 2023 was $0.00.
- SYNLOGIC, INC. restructuring charges for fiscal 2016 was $3.04M.
| Period end | Restructuring Charges 3 month | Restructuring Charges 6 month | Restructuring Charges 9 month | Restructuring Charges 12 month |
|---|---|---|---|---|
| 2026-06-30 | $174.00K 10-Q · filed 2026-08-11 | $380.00K 10-Q · filed 2026-08-11 | $660.00K derived: sum of 3 quarters · filed 2026-08-11 | $825.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $206.00K 10-Q · filed 2026-05-14 | $486.00K derived: sum of 2 quarters · filed 2026-05-14 | $651.00K derived: sum of 3 quarters · filed 2026-05-14 | $642.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $280.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $445.00K derived: sum of 2 quarters · filed 2026-03-12 | $436.00K derived: sum of 3 quarters · filed 2026-08-11 | $476.00K 10-K · filed 2026-03-12 |
| 2025-09-30 | $165.00K 10-Q · filed 2025-11-13 | $156.00K derived: sum of 2 quarters · filed 2026-08-11 | $196.00K 10-Q · filed 2025-11-13 | $579.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | -$9.00K 10-Q · filed 2026-08-11 | $31.00K 10-Q · filed 2026-08-11 | $414.00K derived: sum of 3 quarters · filed 2026-08-11 | $710.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $40.00K 10-Q · filed 2026-05-14 | $423.00K derived: sum of 2 quarters · filed 2026-05-14 | $719.00K derived: sum of 3 quarters · filed 2026-05-14 | -$3.08M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $383.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $679.00K derived: sum of 2 quarters · filed 2026-03-12 | -$3.12M derived: sum of 3 quarters · filed 2026-03-12 | $25.17M 10-K · filed 2026-03-12 |
| 2024-09-30 | $296.00K 10-Q · filed 2025-11-13 | -$3.50M derived: sum of 2 quarters · filed 2025-11-13 | $24.79M 10-Q · filed 2025-11-13 | $24.79M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | -$3.79M 10-Q · filed 2025-08-07 | $24.49M 10-Q · filed 2025-08-07 | $24.49M derived: sum of 3 quarters · filed 2025-08-07 | $24.49M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $28.29M 10-Q · filed 2025-05-08 | $28.29M derived: sum of 2 quarters · filed 2025-05-08 | $28.29M derived: sum of 3 quarters · filed 2025-05-08 | $28.29M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $0.00 derived: sum of 2 quarters · filed 2025-03-06 | $0.00 derived: sum of 3 quarters · filed 2025-03-06 | $0.00 10-K · filed 2025-03-06 |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-12 | $0.00 derived: sum of 2 quarters · filed 2024-11-12 | $0.00 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $0.00 10-Q · filed 2024-08-08 | $0.00 10-Q · filed 2024-08-08 | ||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-14 | |||
| 2017-06-30 | $166.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | $2.72M 10-Q · filed 2017-08-04 | $7.20M 10-Q · filed 2017-08-04 | $7.12M derived: sum of 4 quarters · filed 2017-08-04 |
| 2017-03-31 | $2.56M 10-Q · filed 2017-05-09 | $7.00M 10-Q · filed 2017-05-09 | $6.96M derived: sum of 3 quarters · filed 2017-08-04 | $6.96M derived: sum of 4 quarters · filed 2017-08-04 |
| 2016-12-31 | $4.44M 10-K · filed 2017-03-15 | $4.40M derived: sum of 2 quarters · filed 2017-08-04 | $4.40M derived: sum of 3 quarters · filed 2017-08-04 | $3.04M 10-K · filed 2017-03-15 |
| 2016-09-30 | $0.00 10-K · filed 2017-03-15 | $0.00 derived: sum of 2 quarters · filed 2017-03-15 | $0.00 derived: sum of 3 quarters · filed 2017-03-15 | |
| 2016-06-30 | $0.00 10-K · filed 2017-03-15 | $0.00 derived: sum of 2 quarters · filed 2017-03-15 | ||
| 2016-03-31 | $0.00 10-K · filed 2017-03-15 | |||
| 2015-12-31 | $0.00 10-K · filed 2017-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |